Table 2. Emotional and cardiac effects of the experimental stressor (TSST).
HC (n = 10) | FMS (n = 13) | |
HR_T1 | 75.56±3.29 | 74.62±8.14 |
HR_T2 | 86.56±17.02 | 96.15±18.47 |
HR_T3 | 78.33±15.84 | 74.62±9.47 |
HR_T4 | 76.78±16.4 | 73.69±9.62 |
GLM | F = 2.12; p = .13 | F = 18.15; p<.001 |
SVB_T1 | 13.89±4.81 | 20.31±8.25 |
SVB_T2 | 19.56±10.76 | 28.69±16.56 |
SVB_T3 | 15.00±2.74 | 23.31±9.56 |
SVB_T4 | 14.44±4.72 | 19.54±8.00 |
GLM | F = 2.81; p = .12 | F = 3.72; p = .06 |
VAS_anxiety T1 | 25.67±19.95 | 41.77±28.57 |
VAS_anxiety T2 | 15.33±18.93 | 47.62±25.17 |
VAS_anxiety T3 | 4.33±5.92 | 26.92±20.92 |
GLM | F = 6.27; p = .01 | F = 4.19; p = .03 |
VAS_clinical pain T1 | N.a. | 34.23±20.31 |
VAS_clinical pain T2 | N.a. | 45.54±22.94 |
VAS_clinical pain T3 | N.a. | 42.15±25.51 |
GLM | F = 3.35; p = .052 |
HR = heart rate, SVB = sympathovagal balance, VAS = visual analogue scale.